The report highlights the expanding role of pharmacists in navigating regulatory, financial, logistical, and clinical complexities to ensure safe, equitable, and effective delivery of cell and gene therapies amid a rapidly growing and evolving treatment landscape.
Counseling for behavior change helps patients understand the importance of their medications and make positive changes.
In a session at the 2025 Virtual Conference on Pain and Palliative Care, Isabella Zerfas, PharmD, and Abbey Galligan, PharmD, BCPS, explore effective pain management strategies for opioid use disorder (OUD) and complex persistent opioid dependence.
Experts emphasize the importance of tailored vaccination strategies for pneumococcal based on individual risk factors.
RSV vaccination for older adults requires understanding risk factors, using empathetic communication strategies, and proactively identifying eligible patients through careful review of medical histories and care transitions.
Vo discusses how research and mentorship can enhance practice and patient care.
In a major policy shift, officials from the FDA announced a new regulatory framework for COVID-19 vaccinations, prioritizing adults 65 years and older and individuals with serious comorbidities putting them at high risk for severe COVID-19.
The data were presented at the ESMO Breast Cancer 2025 Annual Meeting.
In premenopausal women, denosumab significantly prevented bone loss and microarchitectural deterioration.
Studies suggest that prolonged activation of MUC1-C encourages disease progression.
The risk of cardiovascular disease (CVD) was higher among those who were exposed to assisted reproductive technology.
The treatment could hold significant potential for major depressive disorder
The combination demonstrated improved efficacy compared with ruxolitinib as a monotherapy.
Research reveals pioglitazone, a diabetes drug, may slow prostate cancer progression, offering new hope for patients with both conditions.
Glofitamab combined with GemOx shows promising survival benefits for patients with relapsed DLBCL, offering a new treatment option for those ineligible for transplants.
A new triple-combination therapy shows promise in improving asthma management, offering hope for millions with uncontrolled symptoms.
Don Moore, PharmD, BCPS, BCOP, DPLA, FCCP, FASHP, received a leadership award at the 2025 HOPA Annual Meeting.
A systematic review reveals declining pediatric pneumococcal complicated pneumonia rates following the introduction of pneumococcal conjugate vaccine 13.
Diabetic ketoacidosis poses serious risks for patients with diabetes, requiring urgent treatment to prevent life-threatening complications and ensure recovery.
Health care professionals play a vital role in preventing overdose and ensuring safe use.
Compared with placebo, patients with cholestatic pruritus and primary biliary cholangitis (PBC) receiving linerixibat experienced improved itch and sleep interference.
Motivational interviewing serves as a beneficial strategy to enhance medication adherence and improve patient outcomes in diabetes management.
Host Craig Beavers speaks with Orly Vardeny, PharmD, MS, a professor of medicine at the University of Minnesota
New research highlights the effectiveness and safety of RSV vaccines for older adults, revealing critical insights into vaccination benefits and risks.
Pharmacists compare real-world practice data with clinical trial results and discuss supportive care options for patients.
The authors believe the results may serve as a foundation for hepatitis D virus (HDV) testing among hepatitis B virus surface antigen (HBsAg)-positive specimens.
The approval expands the therapy’s indication to children as young as 7 years.
A study reveals sasanlimab enhances event-free survival in high-risk bladder cancer patients, offering new hope against disease recurrence.
